Blog Archives

Update: TTIP Civil society response paper to Big Pharma wish list

Nov 7, 2104  When we first published this analysis and joint position on the wish list of the pharmaceutical industry for TTIP, their ambitions were not so transparent with just a few sources of information. By now the intentions and demands pharmaceutical industry have become

See more ›

Posted in Europe, IP, knowledge commons, TTIP

Investor-to-state dispute settlement’ in EU–US trade deal risks access to affordable medicines

Several European and American health NGOs publicly criticised the inclusion of investor-to-state-dispute-settlement (ISDS) in the Transatlantic Trade and Investment Partnership (TTIP) today, warning that it will undermine public health policies of European Union (EU) Member States and severely jeopardise access

See more ›

Posted in Europe, IP, TTIP